Cipla's South African arm completes acquisition of Mirren Ltd Medical Dialogues Bureau24 Oct 2018 9:45 AM ISTNew Delhi: Drug major Cipla has recently stated that its South African subsidiary has completed the acquisition of pharma firm Mirren (Pty) Ltd. Cipla...
Jubilant Life Q2 profit up 67 Percent to Rs 210 Crore Medical Dialogues Bureau24 Oct 2018 9:32 AM ISTNew Delhi: Jubilant Life Sciences has recently reported 67.18 per cent rise in consolidated net profit to Rs 209.77 crore for the quarter ended...
Unregulated sale of prescription medicines: PIL in HC against drug regulators Medical Dialogues Bureau23 Oct 2018 6:07 PM ISTNew Delhi: A Public Interest Litigation (PIL) was filed in Bombay High court by Mumbai based lawyer Bharat Kothari against the Government of...
GSK Pharma Q2 profit down 23 Percent to Rs 101 crore Medical Dialogues Bureau23 Oct 2018 10:03 AM ISTNew Delhi: GlaxoSmithKline(GSK)Pharmaceuticals has reported 22.67 per cent fall in standalone net profit to Rs 100.77 crore for the quarter ended...
IAVI Serum Institute to Develop Affordable Antibody Products for HIV Medical Dialogues Bureau23 Oct 2018 10:00 AM ISTNew Delhi: The International AIDS Vaccine Initiative (IAVI) and Serum Institute of India, the world's largest vaccine manufacturer, today announced a...
Strides Pharma gets USFDA approval for Gabapentin capsules Medical Dialogues Bureau23 Oct 2018 9:10 AM ISTBanglore: Strides Pharmaceutical Science’s step-down wholly-own subsidiary, Strides Pharma Global, Singapore, has received approval for Gabapentin...
Unichem gets EIR from USFDA for Pithampur, Roha facilities Medical Dialogues Bureau23 Oct 2018 9:00 AM ISTNew Delhi: Drug firm Unichem Laboratories has recently announced its active pharmaceutical ingredient (API) manufacturing units at Pithampur and Roha...
Lupin antimyotonic agent receives positive opinion from EMA Medical Dialogues Bureau22 Oct 2018 1:48 PM ISTNaMuscla is an antimyotonic agent which is under review by the European Medicines Agency to treat symptomatic myotonia in adults with non-dystrophic...
J&J hip implants: Affected patients seek clarity on report on compensation amount Medical Dialogues Bureau22 Oct 2018 9:40 AM ISTNew Delhi: Amid reports that the victims of Johnson & Johnson's faulty hip implants are likely to get as much as Rs 1.2 crore each in...
AstraZeneca Lynparza shown to put brakes on ovarian cancer Medical Dialogues Bureau22 Oct 2018 9:20 AM ISTMUNICH - An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a...
Lupin gets USFDA nod for psoriasis treatment spray Medical Dialogues Bureau22 Oct 2018 9:03 AM ISTNew Delhi: Drug major Lupin today said it has received approval from the US health regulator to market Desoximetasone Topical spray, used for...
Merck KGaA says might strike partnership deal this year Medical Dialogues Bureau22 Oct 2018 9:00 AM ISTMUNICH: German drugmaker Merck KGaA might agree on partnership deals to jointly develop two of its most promising experimental medicines with a rival...
